Streetbeat News

Stock Prices

PKX

POSCO Holdings (NYSE:PKX) has seen a decrease in short interest, with the short percent of float falling 4.17% since the last report. The company has 707 thousand shares sold short, representing 0.23% of available shares, with a cover time of 4.52 days. This decline in short interest may indicate a more bullish sentiment among investors, although it does not necessarily predict a near-term price rise. POSCO Holdings has less short interest compared to its peer group average of 4.72%.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 4:45 pm

TMO

Thermo Fisher Scientific (NYSE:TMO) has seen a 15.38% increase in short interest since the last report, with 2.91 million shares sold short, representing 0.75% of available shares. The average time to cover these short positions is 1.42 days. While an increase in short interest can indicate bearish sentiment, it doesn't necessarily predict a price drop. TMO's short interest is below its peer group average of 6.01%.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 4:45 pm

CMC

BMO Capital analyst Katja Jancic has maintained a 'Market Perform' rating on Commercial Metals (NYSE:CMC) and increased the price target from $50 to $52.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 4:43 pm

DTIL

TGTX

Precision BioSciences, Inc. (NASDAQ:DTIL) stock rose after announcing a licensing agreement with TG Therapeutics, Inc. (NASDAQ:TGTX) to develop Azercabtagene Zapreleucel for autoimmune diseases. Precision will receive $17.5 million upfront and could earn up to $288 million in future milestones. The news has significantly increased trading volume for DTIL, with over 26 million shares traded, surpassing the 100-day average of 938,000 shares.

Portfolio Pulse from Erica Kollmann

January 09, 2024 | 4:39 pm

ALAR

Alarum Technologies' shares are up following the company's announcement of FY23 revenue guidance surpassing estimates and a rise in Q4 operating cash flow.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 4:38 pm

ZBH

Zimmer Biomet Holdings, Inc. (ZBH) is presenting at the 42nd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for January 9, 2024, at 11:15 a.m. ET and will be webcast live on the company's Investor Relations website, with an archived replay available post-conference.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 4:37 pm

JBL

Institutional holdings data from Quiver Quantitative shows hedge funds and asset managers, including Fidelity, Point72, and Whale Rock Capital Management, have increased their positions in Jabil Inc. (NYSE:JBL). Fidelity notably raised its stake by 15.86%. Jabil reported solid Q1 FY24 earnings with $8.4 billion in net revenue and provided guidance for Q2 FY24 with expected softer demand. Jabil is a leading global manufacturing services provider with a competitive edge in the EMS and DMS segments. The company's strategy focuses on growth through diversification, customer expansion, and strategic acquisitions. Jabil's management has been returning value to shareholders through share repurchases and dividends, with a recent authorization for a $2.5 billion share repurchase program. Management's compensation is heavily tied to performance, aligning with shareholder interests. Jabil's financial health is strong, with efficient operations, manageable debt, and significant free cash flow growth. A reverse discounted cash flow analysis suggests Jabil's stock is undervalued, with a 'fair' share price estimated at $157, indicating a potential investment opportunity.

Portfolio Pulse from Quiver Quantitative

January 09, 2024 | 4:36 pm

DTIL

TGTX

TG Therapeutics, Inc. (NASDAQ:TGTX) shares are trading lower by 5.2% despite a recent 18% increase over five days. The company has acquired a license for a CAR T cell therapy program, azer-cel, from Precision BioSciences, Inc. (NASDAQ:DTIL) for non-oncology indications. TG Therapeutics will pay Precision $17.5 million upfront and potential near-term payments. The company aims to file an IND for azer-cel by mid-2024. TGTX's stock is above its 50-day moving average and has a high short interest of 29.7%.

Portfolio Pulse from Erica Kollmann

January 09, 2024 | 4:36 pm

ACI

Albertsons Companies Inc (NYSE:ACI) reported a 2.2% increase in Q3 FY23 sales to $18.56 billion, surpassing analyst estimates. Identical sales rose by 2.9%, with pharmacy sales contributing significantly. Digital sales jumped by 21%. However, gross margin rate fell slightly to 28%, and operating income dropped by 2.8% to $566.1 million. Adjusted EBITDA was down 4.4% Y/Y, but adjusted EPS of $0.79 beat estimates of $0.65. The company announced a Q4 dividend of $0.12 per share, payable on February 9, 2024. ACI shares traded down by 0.52% at $22.87.

Portfolio Pulse from Shivani Kumaresan

January 09, 2024 | 4:33 pm

MRVL

Marvell Tech (NASDAQ:MRVL) has delivered an average annual return of 9.19% over the past 20 years, turning a $1000 investment into $5,862.96 today. With a current market capitalization of $54.76 billion, the company has outperformed the market by 1.83% on an annualized basis.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 4:30 pm